NIFFENEGGER KATHI 4
4 · Edesa Biotech, Inc. · Filed Oct 14, 2020
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2020-10-13+50,000→ 50,000 totalExercise: $7.44Exp: 2030-10-13→ Common shares (50,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in equal proportions over 36 months beginning on the Grant Date.